武汉大学人民医院胃肠外科童强教授，负责组稿SCI杂志Biomed Research International (目前影响因子为2.197分)的专题，主题为消化系统肿瘤（食道癌、胃癌、结肠癌、肝癌、胆囊癌、直肠癌、胰腺癌及肛管癌等等）的预防和早期诊断（Prevention and Early detection of Gastrointestinal Cancers)。
收录范围包括1. 消化道肿瘤的体内外实验；2. 消化道肿瘤临床研究；3. 消化道肿瘤的早期发现、分子标志物及诊断；4. 消化道肿瘤的氧化应急微环境及癌前病变；5. 消化道肿瘤的预防策略如使用益生菌、天然产物及新药物来预防消化道肿瘤及炎症。
Prevention and Early Detection of Gastrointestinal Cancers
Call for Papers
Gastrointestinal (GI) cancers, those of the esophagus, stomach, and colon/rectum, are among the most common cancers worldwide. There are more than 4 million new cases each year, which is more than breast and lung cancer cases combined. Despite extensive efforts to improve treatment including the development of new drugs, the prognosis for advanced stages of GI cancers still remains very poor. The early detection of GI cancers before they metastasize to other organs allows definitive local treatment, resulting in excellent survival rates. A defined role for early-detection approaches currently exists in some cancer types, but each approach test has limitations. Primary prevention and early detection have therefore become a major goal of GI cancer research for many years.
The currently available cancer prevention and early-detection approaches have the potential to reduce a large proportion of the cancer burden in the population. However, even if fully implemented, existing methods cannot fully eliminate the cancer burden. Many factors like inflammation, oxidative stress, or nutritional status may play key roles in the pathogenesis of GI cancer. Thus, the aim of this special issue is to identify new preventive and early-detection approaches that exploit the growing knowledge of molecular and biological mechanisms in GI inflammation and cancers. The special issue welcomes basic science and clinical research on early detection or the underlying molecular mechanisms of GI cancer, as well as review articles describing the current state of GI cancer prevention and early detection.
Potential topics include but are not limited to the following:
In vivo or in vitro studies related to GI cancers
Clinical studies in GI cancers
Early detection, biomarker, and diagnosis of GI cancers
Oxidative stress, precancerous lesion, or precancerous conditions in the GI tract
Preventive strategies such as probiotics, prebiotics, synbiotics, natural products, or new drugs to prevent GI inflammation or cancer
Authors can submit their manuscripts through the Manuscript Tracking System at https://mts.hindawi.com/submit/journals/bmri/oncology/edoc/.
Submission Deadline Friday, 26 July 2019
Publication Date December 2019
Papers are published upon acceptance, regardless of the Special Issue publication date.
Lead Guest Editor
Qiang Tong, Wuhan University, Wuhan, China
Guoku Hu, University of Nebraska Medical Center, Omaha, USA
Hongxiang Chen, Huazhong University of Science and Technology, Wuhan, China
Bin Duan, University of Nebraska Medical Center, Omaha, USA
Xiao-Jie Lu, Nanjing Medical University, Nanjing, China